Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody)

被引：39

作者：

Burt, MJ ^{[1
]}

Frizelle, FA

Barbezat, GO

机构：

[1] Christchurch Sch Med & Hlth Sci, Christchurch, New Zealand

[2] Dunedin Sch Med, Dunedin, New Zealand

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2003年 / 18卷 / 04期

关键词：

D O I：

10.1046/j.1440-1746.2003.02983.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：465 / U3

页数：2

共 4 条

[1] Outcome of pregnancy in women receiving REMICADE® (infliximab) for the treatment of Crohn's disease or rheumatoid arthritis [J].

Katz, JA ;

Lichtenstein, GR ;

Keenan, GF ;

Healy, DE ;

Jacobs, SJ .

GASTROENTEROLOGY, 2001, 120 (05) :A69-A69

[2] Infliximab for the treatment of fistulas in patients with Crohn's disease [J].

Present, DH ;

Rutgeerts, P ;

Targan, S ;

Hanauer, SB ;

Mayer, L ;

van Hogezand, RA ;

Podolsky, DK ;

Sands, BE ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

van Deventer, SJH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18) :1398-1405

[3] Infliximab treatment and pregnancy outcome in active Crohn's disease [J].

Srinivasan, R .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (07) :2274-+

[4] A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease [J].

Targan, SR ;

Hanauer, SB ;

vanDeventer, SJH ;

Mayer, L ;

Present, DH ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

Rutgeerts, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15) :1029-1035

← 1 →